The pathway of delivering complex therapies to their destinations is peppered with pitfalls from the manufacturing process to maintaining extremely sensitive components in a controlled environment in transit. This panel highlights how different organizations in the biopharma supply chain are addressing the inherent challenges of producing and delivering cell and gene therapies and biologics.
Moderator: Frank Vinluan, Senior Reporter, MedCity News
- Joe DePinto, Chief Commercial Officer, Vineti
- Jason Foster, CEO, Ori Biotech
- Claudia Zylberberg, PhD, Founder & CEO, Akron Biotechnology